Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea · Delayed Price · Currency is KRW

11,400

+220 (1.97%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals					371.35B	343.33B	324.57B	300.04B	269.81B
Pharmaceuticals Growth					8.16%	5.78%	8.18%	11.20%	3.13%
Total					371.35B	343.33B	324.57B	300.04B	269.81B
Total Growth					8.16%	5.78%	8.18%	11.20%	3.13%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea					207.67B	-	-	-	-
Overseas					163.68B	-	-	-	-
Total					371.35B	-	-	-	-

Source: S&P Global Market Intelligence.